US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist
  • 3.6050
  • +0.0450+1.26%
Close Nov 29 13:00 ET
  • 3.4600
  • -0.1450-4.02%
Post 17:01 ET
559.30MMarket Cap-12016P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mereo BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.589M--
--2024/Q4-- / 11.374M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2022/Q4-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.589M--
--2024/Q4-- / 11.374M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2022/Q4-- / 0.000--

Unlock Free Earnings Estimates

Mereo BioPharma Earnings Reports

  • Mereo BioPharma | 10-Q: Quarterly report

    Nov 12 12:40 ET

  • Mereo BioPharma | 8-K: Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 12 12:40 ET

  • Mereo BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 13 08:22 ET

  • Mereo BioPharma | 8-K: Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 13 08:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data